In February, the German Atrial Fibrillation Network (AFNET) enrolled the first patients in the AXAFA – AFNET 5 trial. The trial is designed to test whether novel oral anticoagulants (NOACs) are also suitable for stroke prevention in atrial fibrillation patients undergoing...
Read more
